Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Kane

Showing results (11-20 of 249) with videos related to

Pageof 25
Sort By:
The British Journal of Psychiatry. Supplement|May 1, 1992
Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overviewJ M Kane
The Journal of Clinical Psychiatry|November 1, 1988
The role of neuroleptics in manic-depressive illnessJ M Kane
The Journal of Clinical Psychiatry|September 1, 1989
The current status of neuroleptic therapyJ M Kane
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 6, 2001
Extrapyramidal side effects are unacceptableJ M Kane
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Treatment programme and long-term outcome in chronic schizophreniaJ M Kane
Neuropsychobiology|January 1, 1997
The use of scales for clinical monitoring of disease progression and the treatment of schizophreniaJ M Kane
The American Journal of Psychiatry|November 1, 1996
Commentary on the clozapine conflictJ M Kane
Bulletin of the Menninger Clinic|January 1, 1992
New developments in the pharmacological treatment of schizophreniaJ M Kane
Geriatrics|December 1, 1982
Coping with a drug-induced movement disorder: tardive dyskinesiaJ M Kane
The Journal of Clinical Psychiatry|June 1, 1983
Problems of compliance in the outpatient treatment of schizophreniaJ M Kane
Pageof 25

Showing results (11-20 of 249) with videos related to

Sort By:
Pageof 25
The British Journal of Psychiatry. Supplement|May 1, 1992
Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overviewJ M Kane
The Journal of Clinical Psychiatry|November 1, 1988
The role of neuroleptics in manic-depressive illnessJ M Kane
The Journal of Clinical Psychiatry|September 1, 1989
The current status of neuroleptic therapyJ M Kane
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 6, 2001
Extrapyramidal side effects are unacceptableJ M Kane
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Treatment programme and long-term outcome in chronic schizophreniaJ M Kane
Neuropsychobiology|January 1, 1997
The use of scales for clinical monitoring of disease progression and the treatment of schizophreniaJ M Kane
The American Journal of Psychiatry|November 1, 1996
Commentary on the clozapine conflictJ M Kane
Bulletin of the Menninger Clinic|January 1, 1992
New developments in the pharmacological treatment of schizophreniaJ M Kane
Geriatrics|December 1, 1982
Coping with a drug-induced movement disorder: tardive dyskinesiaJ M Kane
The Journal of Clinical Psychiatry|June 1, 1983
Problems of compliance in the outpatient treatment of schizophreniaJ M Kane
Pageof 25